Chemical Compound

Lamivudine; 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-; 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; 2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; 3TC; BCH 189, (-)-; Epivir; Epivir HBV; GR 109714X; Hepitec; Heptodin; Heptovir; L-SddC; Lamivir; Virolam; Zeffix; Zefix; cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; beta-L-2',3'-Dideoxy-3'-thiacytidine; beta-L-3'-Thia-2',3'-dideoxycytidine; GR 109714X; 3TC; GR 111720X; GR 135522X; Lamivudine GR109714X; BP Zidovudine and Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 1; BP Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 2

CAS Registry Number 134678-17-4
返回搜索 申请报价
Lamivudine; 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-; 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; 2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; 3TC; BCH 189, (-)-; Epivir; Epivir HBV; GR 109714X; Hepitec; Heptodin; Heptovir; L-SddC; Lamivir; Virolam; Zeffix; Zefix; cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; beta-L-2',3'-Dideoxy-3'-thiacytidine; beta-L-3'-Thia-2',3'-dideoxycytidine; GR 109714X; 3TC; GR 111720X; GR 135522X; Lamivudine GR109714X; BP Zidovudine and Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 1; BP Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 2 结构式
Primary record

Lamivudine; 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-; 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; 2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; 3TC; BCH 189, (-)-; Epivir; Epivir HBV; GR 109714X; Hepitec; Heptodin; Heptovir; L-SddC; Lamivir; Virolam; Zeffix; Zefix; cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; beta-L-2',3'-Dideoxy-3'-thiacytidine; beta-L-3'-Thia-2',3'-dideoxycytidine; GR 109714X; 3TC; GR 111720X; GR 135522X; Lamivudine GR109714X; BP Zidovudine and Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 1; BP Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 2

库存
9,853 克
纯度
98.7 %
CAS
134678-17-4

化合物标识与属性

CAS
134678-17-4
PubChem CID
60825
SMILES
C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
Canonical SMILES
Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1

名称与同义词

  • lamivudine
  • Epivir
  • Zeffix
  • Heptovir
  • Epivir-HBV
  • 134678-17-4
  • Hepitec
  • Heptodin
  • Lamivir
  • Zefix
  • Heptivir
  • Lamivudine teva
  • Lamivudina
  • Lamivudinum
  • Combivir
  • Trizivir
  • Epzicom
  • VIROLAM
  • lamivudine oral
  • Kuvan
  • CIS-LAMIVUDINE
  • Epivir HBV
  • Lamivudine ViiV
  • Mixture Name
  • Lamivudine RS
  • Epivir(TM)
  • Lamivudine CRS
  • Epivir;
  • HHA & Lamivudine
  • Lamivudine & GNA
  • 3TC Lamivudine
  • Epivir (TN)
  • DTHC
  • Lamivudine, 3TC
  • BCH-189
  • Heptovir (TN)
  • (-)-2'-Deoxy-3'-thiacytidine
  • Zeffix (TN)
  • 2',3'-Dideoxy-3'-thiacytidine
  • 3'-Thia-2',3'-dideoxycytidine
  • C8H11N3O3S
  • Epivir-HBV (TN)
  • GR-109714X
  • GR109714X
  • Lamivudine (Standard)
  • Lamivudine [USAN:BAN:INN]
  • (-)-BCH-189
  • Lamivudine (EPIVIR)
  • 3TC and NV-01
  • BCH 189
  • L-SDDC
  • (-)-SddC
  • LAMIVUDINE [MI]
  • Lamivudine [USAN:INN:BAN]
  • AC1L1TZZ
  • LAMIVUDINE [INN]
  • LAMIVUDINE [JAN]
  • RefChem:798426
  • BCH189
  • LAMIVUDINE [HSDB]
  • LAMIVUDINE [USAN]
  • 136891-12-8
  • beta-L-2',3'-Dideoxy-3'-thiacytidine
  • beta-L-3'-Thia-2',3'-dideoxycytidine
  • (-)NGPB-21
  • Lamivudine (JAN/USP/INN)
  • 3TC & GNA
  • 3TC & SST
  • HHA & 3TC
  • LAMIVUDINE [VANDF]
  • CHEBI:63577
  • CHEMBL141
  • D07TQV
  • D0V7DY
  • Epitope ID:613392
  • (+/-)-SddC
  • HSDB 7155
  • LAMIVUDINE [MART.]
  • CCRIS 9274
  • GR 109714X
  • LAMIVUDINE [USP-RS]
  • LAMIVUDINE [WHO-DD]
  • LAMIVUDINE [WHO-IP]
  • Lamivudine, cis-(+/-)-
  • US4RZW252L
  • 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
  • MFCD00869739
  • BCH 189, (-)-
  • DTXSID7023194
  • UNII-2T8Q726O95
  • DRG-0126
  • MLS000759424
  • MLS001424097
  • MLS006011910
  • BIDD:GT0033
  • LAMIVUDINE [EMA EPAR]
  • SCHEMBL109675
  • 2',3' Dideoxy 3' thiacytidine
  • 3TC
  • BCH-790
  • Lamivudine, (2S-cis)-Isomer
  • (-)-BCH 189
  • GG-714
  • JTEGQNOMFQHVDC-NKWVEPMBSA-N
  • 3-TC
  • AC1Q6C34
  • AMY384
  • Lamivudine - Bio-X trade mark
  • Lamivudine [USAN:USP:INN:BAN]
  • orb1310390
  • PYR356
  • TRIUMEQ COMPONENT LAMIVUDINE
  • (-)-beta-L-BCH-189
  • 2T8Q726O95
  • LAMIVUDINE [EP IMPURITY]
  • LAMIVUDINE [ORANGE BOOK]
  • LAMIVUDINE TEVA PHARMA B.V.
  • NSC-760061
  • TRIZIVIR COMPONENT LAMIVUDINE
  • CTK3J2124
  • GTPL12673
  • HY-B0250R
  • ZINC12346
  • DELSTRIGO COMPONENT LAMIVUDINE
  • J05AF05
  • LAMIVUDINE [EP MONOGRAPH]
  • 2 -Deoxy-3 -thiacytidine
  • KIVEXA COMPONENT LAMIVUDINE
  • MFCD00870542
  • DTXCID001508532
  • GLXC-05058
  • HMS2051D21
  • HMS3259F08
  • HMS3713C16
  • LAMIVUDINE [USP MONOGRAPH]
  • EPZICOM COMPONENT LAMIVUDINE
  • LAMIVUDINUM [WHO-IP LATIN]
  • TEMIXYS COMPONENT LAMIVUDINE
  • (-)-NGPB-21
  • ALBB-038661
  • CID60825
  • COMBIVIR COMPONENT LAMIVUDINE
  • HY-B0250
  • MSK10170
  • C8-H11-N3-O3-S
  • Lamivudine for system suitability RS
  • 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
  • ANW-43098
  • BBF-04130
  • BBL033871
  • BDBM50366817
  • CL0014
  • EBC-03887
  • NSC620753
  • s1706
  • SBB066293
  • STK801940
  • CPD000466319
  • lamivudine & TNF-alpha & IFN-gamma
  • 4-Amino-1-(cis-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
  • 4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-2(1H)-PYRIMIDINONE
  • AKOS005622556
  • AKOS015854841
  • Efavirenz/lamivudine/tenofovir fumarate
  • Lamivudine, >=98% (HPLC), powder
  • (+/-)-3TC
  • (+/-)-BCH-189
  • (-)-BCH189
  • AC-1416
  • ACN-029244
  • AN-7245
  • CCG-100984
  • CS-2230
  • DB00709
  • KS-1073
  • LS-2107
  • NC00234
  • NC00705
  • NL06295
  • NSC 760061
  • RL01569
  • RTC-020973
  • (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
  • (-)-2 -Deoxy-3 -thiacytidine
  • KS-0000023D
  • Lamivudine for system suitability 1 CRS
  • 4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE
  • NCGC00159341-04
  • NCGC00159341-05
  • NCGC00159341-18
  • NCGC00159341-20
  • (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine
  • AJ-08348
  • BC206089
  • BCH 189 (-)-
  • BL164607
  • CJ-00130
  • EMTRICITABINE IMPURITY C [WHO-IP]
  • SAM001246582
  • SAM002589994
  • SC-15184
  • SMR000466319
  • ZB000700
  • 3TC (AIDS INITIATIVE) (AIDS INITIATIVE)
  • J457.051K
  • (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
  • 1 3-Oxathiolane 2(1H)-pyrimidinone deriv.
  • L0217
  • NS00007004
  • rac-cis-Lamivudine ((2RS,5SR)-Lamivudine)
  • ST24030826
  • SW197614-3
  • 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
  • C07065
  • D00353
  • EN300-123034
  • J10244
  • Lamivudine 100 microg/mL in Acetonitrile:Water
  • M-9795
  • P17147
  • 24222-EP2269989A1
  • 24222-EP2272516A2
  • 24222-EP2272825A2
  • 24222-EP2292227A2
  • 24222-EP2298761A1
  • 24222-EP2298783A1
  • 24222-EP2305243A1
  • 24222-EP2305640A2
  • 24222-EP2305680A2
  • 24222-EP2314590A1
  • 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
  • AB00639995-06
  • AB00639995-08
  • AB00639995_09
  • beta-L-2 ,3 -Dideoxy-3 -thiacytidine
  • LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT LAMIVUDINE
  • 200973-EP2272825A2
  • 678L174
  • A998898
  • F227713
  • Q422631
  • SR-01000759420
  • (-)-2 ,3 -Dideoxy-3 -thia-L-cytidine
  • 2-Hydroxymethyl-5-(cytosin-1-yl)-1 3-oxathiolane
  • A1199077
  • SR-01000759420-5
  • 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-
  • BRD-K02992638-001-11-8
  • 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine
  • Z1509637175
  • (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine
  • 2(1H)-Pyrimidinone, 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-
  • 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-
  • cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1 3-oxathiolane
  • Lamivudine Working Standard (Secondary Reference Standard)
  • Lamivudine, British Pharmacopoeia (BP) Reference Standard
  • Lamivudine, European Pharmacopoeia (EP) Reference Standard
  • (2R,5S)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
  • .beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
  • 1-[(2R)-2-(Hydroxymethyl)-1,3-oxathiolane-5beta-yl]cytosine
  • Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
  • cis(+/-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane
  • cis-(+/-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane
  • Lamivudine, United States Pharmacopeia (USP) Reference Standard
  • (+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
  • (+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
  • (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cystosine
  • (-)-1-[(2R,5S)-2-Hydroxymethyl-1,3-oxathiolan-5-yl]cytosine
  • (-)-L-2',3'-DIDEOXY-3'-THIACYTIDINE; LAMIVUDINE; EPIVIR
  • (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
  • 1-[(2R)-2beta-(Hydroxymethyl)-1,3-oxathiolan-5beta-yl]cytosine
  • 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-
  • 2(1H)-Pyrimidinone,4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-
  • Lamivudine, 1.0 mg/mL in methanol, certified reference material
  • (-)-1-[(2R,5S)-2beta-(Hydroxymethyl)-1,3-oxathiolan-5beta-yl]cytosine
  • 131086-21-0
  • Lamivudine, Pharmaceutical Secondary Standard; Certified Reference Material
  • LMV
  • (+/-)-(cis)-4-Amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
  • (-)-4-Amino-1-[(2R)-2beta-hydroxymethyl-1,3-oxathiolan-5beta-yl]-pyrimidin-2(1H)-one
  • 1-[(2R)-2beta-Hydroxymethyl-1,3-oxathiolan-5beta-yl]-4-aminopyrimidin-2(1H)-one
  • 2(1h)-pirimidinona, 4-amino-1-[(2r,5s)-2-(hidroximetil)-1,3-oxatiolan-5-il]-
  • 2(1H)-Pyrimidinone 4-amino-1-[2-(hydroxymethyl)-1 3-oxathiolan-5-yl]-(2R-cis)-
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-)-(Cis)
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S)
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-(+/-)-
  • 3-[(5S,2R)-2-(hydroxymethyl)(1,3-oxathiolan-5-yl)]-6-amino-3-hydropyrimidin-2- one
  • 4-Amino 1-[2beta-(hydroxymethyl)-1-oxa-3-thiacyclopentane-5beta-yl]pyrimidine-2(1H)-one
  • 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-1,2-dihydropyrimidin-2-one
  • 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2-one
  • 4-Amino-1-[(2R)-2beta-(hydroxymethyl)-1,3-oxathiolane-5beta-yl]pyrimidine-2(1H)-one
  • 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-[1,3]-oxathiolan-5-yl]-(1H)-pyrimidin-2-one
  • 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-Oxathiolan-5-yl]-(1H)-pyrimidin-2-one
  • 4-Amino-1-[(2R,5S)-2-hydroxymethyl-1,3-oxathiolane-5-yl]pyrimidine-2(1H)-one
  • 4-Amino-1-[2beta-(hydroxymethyl)-1,3-oxathiolane-5beta-yl]pyrimidine-2(1H)-one
  • cis(+/-)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
  • Lamivudine for system suitability 1, European Pharmacopoeia (EP) Reference Standard
  • Lamivudine for system suitability 2, European Pharmacopoeia (EP) Reference Standard
  • Lamivudine, 98%, a potent nucleoside analog reverse transcriptase inhibitor - 100MG 100mg
  • rel-4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
  • 1117764-41-6
  • 134680-32-3
  • 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-(+/-)-; 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.; rel-4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, cis-; BCH 189; cis(+/-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; cis-(+/-)-Lamivudine; (2RS,5SR)-Lamivudine
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
  • 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Hippeastrum hybrid agglutinin(HHA)
  • 4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE [WHO-IP]
  • 603-844-3
  • Lamivudine; 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-; 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv.; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; 2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; 3TC; BCH 189, (-)-; Epivir; Epivir HBV; GR 109714X; Hepitec; Heptodin; Heptovir; L-SddC; Lamivir; Virolam; Zeffix; Zefix; cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane; beta-L-2',3'-Dideoxy-3'-thiacytidine; beta-L-3'-Thia-2',3'-dideoxycytidine; GR 109714X; 3TC; GR 111720X; GR 135522X; Lamivudine GR109714X; BP Zidovudine and Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 1; BP Lamivudine Impurity Standard; Ph Eur Lamivudine for system suitability 2